Skip to main content

Table 4 Antimicrobial susceptibility of 111 Enterobacteriaceae isolates recovered from patients with CTXNS-En and CTXS-En bacteremia

From: Clinical and microbiologic characteristics of cefotaxime-non-susceptible Enterobacteriaceae bacteremia: a case control study

Antimicrobial agent

No. (%)

 

P-value

CTXNS-En (n = 37)

CTXS-En (n = 74)

Ceftazidime

5 (14%)

73 (99%)

<0.01

Cefozopran

12 (32%)

73 (99%)

<0.01

Cefepime

21 (57%)

70 (95%)

<0.01

Flomoxefa

22 (59%)

56 (76%)

0.12

Meropenem

36 (97%)

74 (100%)

<0.33

Amoxicillin-clavulanate

13 (35%)

46 (62%)

<0.01

Piperacillin-tazobactam

25 (68%)

74 (100%)

<0.01

Amikacin

37 (100%)

74 (100%)

1.00

Gentamicin

28 (76%)

64 (86%)

0.18

Ciprofloxacin

18 (49%)

65 (88%)

<0.01

Levofloxacin

19 (51%)

65 (88%)

<0.01

Sulfamethoxazole-trimethoprim

20 (54%)

57 (77%)

0.02

Multidrug resistance

26 (70%)

10 (14%)

<0.01

  1. The CLSI breakpoints (M100-S19) were used as interpretive criteria
  2. aIsolates were regarded as susceptible to flomoxef at an MIC of ≤ 8 μg/mL